The real cost of expired stock — and how to see it coming

Ask any pharmacy owner what their biggest silent cost is, and expiry comes up fast. Industry estimates put average loss at around 8% of stock value — not from theft or damage, but from medicine that simply sat on a shelf past its date.

The frustrating part is that almost none of that stock was truly unsellable in advance. A batch nearing expiry in four months is still perfectly good today. The problem isn't the medicine — it's that nobody flagged it early enough to discount it, return it to the distributor, or move it to a branch that would sell through it in time.

Manual tracking fails here because it depends on someone remembering to check dates, batch by batch, shelf by shelf. That doesn't scale past a handful of SKUs, and pharmacies routinely carry thousands.

dawaTech tracks every unit by batch and expiry date automatically, and flags near-expiry stock in amber six, three, and one months out — with a suggested action attached: discount it, return it to the distributor, or transfer it to a branch with better turnover. The decision is still yours; the visibility just arrives early enough to act on it.

The pharmacies that get the most out of this aren't doing anything exotic — they're just seeing the problem three months before it becomes a write-off instead of on the day it does.

See dawaTech on your own data

A 30-minute walkthrough with your stock list. No commitment.